Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines

被引:33
作者
Gomez-Martinez, Angeles
Garcia-Morales, Pilar
Carrato, Alfredo
Castro-Galache, Maria D.
Soto, Jose L.
Carrasco-Garcia, Estefania
Garcia-Bautista, Miriam
Guaraz, Patricia
Ferragut, Jose A.
Saceda, Miguel [1 ]
机构
[1] Univ Miguel Hernandez, Inst Mol & Cellular Biol, Alicante 03202, Spain
[2] Hosp Univ Elche, Alicante 03203, Spain
关键词
D O I
10.1158/1541-7786.MCR-06-0177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study of inhibitors shows that the histone deacetylase-induced increase in P-glycoprotein (Pgp) mRNA (MDR1 mRNA) does not parallel either an increase in Pgp protein or an increase in Pgp activity in several colon carcinoma cell lines. Furthermore, studying the polysome profile distribution, we show a translational control of Pgp in these cell lines. In addition, we show that the MDR1 mRNA produced in these cell lines is shorter in its 5 ' end that the MDR1 mRNA produced in the MCF-7/Adr (human breast carcinoma) and K562/Adr (human erythroleukemia) cell lines, both of them expressing Pgp. The different size of the MDR1 mRNA is due to the use of alternative promoters. Our data suggest that the translational blockade of MDR1 mRNA in the colon carcinoma cell lines and in wild-type K562 cells could be overcome by alterations in the 5 ' end of the MDR1 mRNA in the resistant variant of these cell lines, as in the case of the K562/Adr cell line. This is, to our knowledge, the first report demonstrating that the presence of an additional 5 ' untranslated fragment in the MDR1 mRNA improves the translational efficiency of this mRNA.
引用
收藏
页码:641 / 653
页数:13
相关论文
共 32 条
[1]   Functional incorporation of P-glycoprotein into Xenopus oocyte plasma membrane fails to elicit a swelling-evoked conductance [J].
Aleu, J ;
Ivorra, I ;
Lejarreta, M ;
GonzalezRos, JM ;
Morales, A ;
Ferragut, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (02) :407-412
[2]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[3]   Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells [J].
Budworth, J ;
Gant, TW ;
Gescher, A .
BRITISH JOURNAL OF CANCER, 1997, 75 (09) :1330-1335
[4]   Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors [J].
Castro-Galache, MD ;
Ferragut, JA ;
Barbera, VM ;
Martín-Orozco, E ;
Gonzalez-Ros, JM ;
Garcia-Morales, P ;
Saceda, M .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (05) :579-586
[5]   CCAAT/enhancer-binding protein β (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells [J].
Chen, GK ;
Sale, S ;
Tan, T ;
Ermoian, RP ;
Sikic, BI .
MOLECULAR PHARMACOLOGY, 2004, 65 (04) :906-916
[6]   The human ATP-binding cassette (ABC) transporter superfamily [J].
Dean, M ;
Rzhetsky, A ;
Allikmets, R .
GENOME RESEARCH, 2001, 11 (07) :1156-1166
[7]  
Garcia-Morales P, 2002, AV DIABETOL, V18, P175
[8]   Mechanisms of cancer drug resistance [J].
Gottesman, MM .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :615-627
[9]   Multidrug resistance in cancer: Role of ATP-dependent transporters [J].
Gottesman, MM ;
Fojo, T ;
Bates, SE .
NATURE REVIEWS CANCER, 2002, 2 (01) :48-58
[10]   Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia [J].
He, LZ ;
Tolentino, T ;
Grayson, P ;
Zhong, S ;
Warrell, RP ;
Rifkind, RA ;
Marks, PA ;
Richon, VM ;
Pandolfi, PP .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (09) :1321-1330